What is the strategic rationale behind Colgate-Palmolive's acquisition of Filorga?

The acquisition of Filorga is a strategic move by Colgate-Palmolive to expand its presence in the premium skincare market. Filorga is known for its dermo-cosmetic products, which will likely complement Colgate's existing portfolio and tap into a growing consumer demand for advanced skincare solutions.

What is the total cost of the acquisition?

The equity purchase price for Laboratoires Filorga Cosmétiques is €1,495.5 million in cash. The final price may be adjusted at closing to account for the company's cash, debt, and working capital balances from January 1, 2019.

Are there any significant conditions that need to be met for the deal to close?

Yes, the transaction is subject to several closing conditions. Key among these are obtaining approval from the Austrian Federal Competition Authority, the French Competition Authority, and the Federal Antimonopoly Service of the Russian Federation. There must also be no governmental orders or laws prohibiting the transaction.

When is the expected closing date for the acquisition?

The Share Purchase Agreement sets a termination date of December 31, 2019, if the closing conditions are not met by then. However, both Colgate and Filorga have the right to extend this date to March 31, 2020, without needing each other's consent.

CL 8-K SEC Disclosure — Jul 11, 2019

Summary

Colgate-Palmolive Company (CL) announced on July 11, 2019, a significant strategic move: the acquisition of Laboratoires Filorga Cosmétiques for an equity purchase price of €1,495.5 million in cash. This acquisition positions Colgate to expand its presence in the premium skincare market, leveraging Filorga's established brand and product portfolio. The transaction is subject to customary closing conditions, including regulatory approvals from competition authorities in Austria, France, and Russia. The deal also includes provisions for working capital adjustments and interest on the purchase price from January 1, 2019, to the closing date. This move signals Colgate's intent to pursue growth through targeted acquisitions in attractive consumer segments.

Key Highlights

1Colgate-Palmolive to acquire Laboratoires Filorga Cosmétiques for €1,495.5 million in cash.
2The acquisition aims to strengthen Colgate's position in the premium skincare market.
3Transaction subject to approval from Austrian, French, and Russian competition authorities.
4Deal includes adjustments for cash, debt, and working capital accrued since January 1, 2019.
5Closing conditions have a termination date of December 31, 2019, with potential extension to March 31, 2020.
6Representation and warranty insurance has been obtained for the transaction.
7Filorga will be subject to non-compete and employee non-solicitation obligations for three years post-closing.

COLGATE PALMOLIVE CO 8-K Report, Corporate Update (Jul 11, 2019)

Summary

Key Highlights

Frequently Asked Questions